Page 351 - 20dynamics of cancer

336 REFERENCES

Backvall, H., Asplund, A., Gustafsson, A., Sivertsson, A., Lundeberg, J., and Pon-
ten, F. 2005. Genetic tumor archeology: microdissection and genetic hetero-
geneity in squamous and basal cell carcinoma. Mutation Research/Funda-
mental and Molecular Mechanisms of Mutagenesis 571:65–79.
Bahar, R., Hartmann, C. H., Rodriguez, K. A., Denny, A. D., Busuttil, R. A., Dolle,
M. E., Calder, R. B., Chisholm, G. B., Pollock, B. H., Klein, C. A., and Vijg, J.
2006. Increased cell-to-cell variation in gene expression in ageing mouse
heart. Nature 441:1011–1014.
Bapat, S. A. 2006. Evolution of cancer stem cells. Seminars in Cancer Biology
[doi:10.1016/j.semcancer.2006.05.001].
Barbacid, M. 1987. ras genes. Annual Review of Biochemistry 56:779–827.
Barton, N. H., and Keightley, P. D. 2002. Understanding quantitative genetic
variation. Nature Reviews Genetics 3:11–21.
Beckman, R. A., and Loeb, L. A. 2005. Genetic instability in cancer: theory and
experiment. Seminars in Cancer Biology 15:423–435.
Berenblum, I. 1941. The cocarcinogenic action of croton resin. Cancer Research
1:44–48.
Berenblum, I., and Shubik, P. 1947a. A new, quantitative approach to the study
of stages of chemical carcinogenesis in the mouse’s skin. British Journal of
Cancer 1:383–391.
Berenblum, I., and Shubik, P. 1947b. The role of croton oil applications as-
sociated with a single painting of a carcinogen in tumour induction of the
mouse’s skin. British Journal of Cancer 1:379–382.
Berenblum, I., and Shubik, P. 1949. The persistence of latent tumour cells
induced in the mouse’s skin by a single application of 9:10-dimethyl-1:2-
benzanthracene. British Journal of Cancer 3:384–386.
Bernstein, C., Bernstein, H., Payne, C. M., and Garewal, H. 2002. DNA repair/pro-
apoptotic dual-role proteins in five major DNA repair pathways: fail-safe pro-
tection against carcinogenesis. Mutation Research 511:145–178.
Berwick, M., and Vineis, P. 2000. Markers of DNA repair and susceptibility to
cancer in humans: an epidemiologic review. Journal of the National Cancer
Institute 92:874–897.
Boland, C. R. 2002. Heredity nonpolyposis colorectal cancer (HNPCC). In Vogel-
stein, B., and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd
edition)., pp. 307–321. McGraw-Hill, New York.
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti,
J., Bartel, F., Taubert, H., Wuerl, P., Onel, K., Yip, L., Hwang, S. J., Strong, L. C.,
Lozano, G., and Levine, A. J. 2004. A single nucleotide polymorphism in the
MDM2 promoter attenuates the p53 tumor suppressor pathway and acceler-
ates tumor formation in humans. Cell 119:591–602.
Bonsing, B. A., Corver, W. E., Fleuren, G. J., Cleton-Jansen, A. M., Devilee, P.,
and Cornelisse, C. J. 2000. Allelotype analysis of flow-sorted breast cancer
cells demonstrates genetically related diploid and aneuploid subpopulations